LYB
27
-3
FRT
48
2
TXT
49
-11
CMA
61
3
CPB
32
-2
ORCL
55
3
DNB
56
8
USB
59
2
PFE
30
-2
RCL
68
6
ECL
52
-2
ZTS
12
-4
ADM
33
-3
HBI
62
3
MSFT
50
3
SRE
42
2
LEG
13
4
MMM
56
2
PFG
52
3
MAS
54
3
LYB
27
-3
FRT
48
2
TXT
49
-11
CMA
61
3
CPB
32
-2
ORCL
55
3
DNB
56
8
USB
59
2
PFE
30
-2
RCL
68
6
ECL
52
-2
ZTS
12
-4
ADM
33
-3
HBI
62
3
MSFT
50
3
SRE
42
2
LEG
13
4
MMM
56
2
PFG
52
3
MAS
54
3
Financhill
Back

National Australia Bank Vs. Monopar Therapeutics Industry Stock Comparison

Sell
22

NABZY
National Australia Bank

Last Price:
$10.40
Seasonality Move:
-0.49%
Buy
53

MNPR
Monopar Therapeutics

Last Price:
$44.56
Seasonality Move:
-13.48%
Sell
22
National Australia Bank (NABZY) is a Sell

Is National Australia Bank a Buy, Sell or Hold?

  • The current National Australia Bank [NABZY] share price is $10.32. The Score for NABZY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NABZY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $39.10. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NABZY Stock Price Chart

What is National Australia Bank's stock price today?

  • The National Australia Bank share price today is $10.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NABZY is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $39.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.

NABZY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 33.39 Sell
Chaikin Money Flow: -118763 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.15 Sell
Relative Strength Index (14 RSI): 58.89 Buy
Chaikin Money Flow: 4038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NABZY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.49 Sell
20-day SMA: 10.89 Sell
50-day SMA: 11.72 Sell
200-day SMA: 12.25 Sell
8-day EMA: 10.5 Sell
20-day EMA: 10.93 Sell
50-day EMA: 11.51 Sell
200-day EMA: 11.88 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.95 Buy
20-day SMA: 33.91 Buy
50-day SMA: 35.65 Buy
200-day SMA: 15.78 Buy
8-day EMA: 33.66 Buy
20-day EMA: 34.36 Buy
50-day EMA: 33.62 Buy
200-day EMA: 20.42 Buy

National Australia Bank Earnings Growth & NABZY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.00 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

National Australia Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):